Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)" [Gynecol. Oncol. Rep. 31 (2020) 100532]

Saved in:

Bibliographic Details
Main Authors:	Alessandro D. Santin (Author), Virginia Filiaci (Author), Stefania Bellone (Author), Roisin O'Cearbhaill (Author), Elena S. Ratner (Author), Cara A. Mathews (Author), Guilherme Cantuaria (Author), Camille C. Gunderson (Author), Teresa Rutledge (Author), Barbara M. Buttin (Author), Heather A. Lankes (Author), Michael J. Birrer (Author)
Format:	Book
Published:	Elsevier, 2020-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

Holdings details from 3rd Floor Main Library
Call Number:	A1234.567
Copy 1	Available